Latest filing published 15 Dec 2006 for KOS PHARMACEUTICALS INC, €83.8M.
No signal scores available.
Mary Jaharis is a declared insider of KOS Pharmaceuticals Inc, with filings sourced from SEC (Form 4). In total, 11 filings cover trades dated from 4 March 2006 to 13 December 2006.
None of the filings is a plain purchase or sale on the open market; they cover grants, option exercises and other movements. Such operations are usually part of compensation schedules, which makes them a weaker signal than an open-market trade.
The newest entry dates from 15 December 2006: a transaction of €56.7M, in KOS Pharmaceuticals Inc. Between a trade and the moment it shows up on SEC (Form 4), the median delay is 2 days. For comparison, the SEC allows two business days to file a Form 4. Every figure here comes from the filings published by SEC (Form 4) and describes the past, not future prices; it is not investment advice.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
11 of 11 declarations